Axid

Active Ingredient(s): Nizatidine
FDA Approved: * April 12, 1988
Pharm Company: * RELIANT PHARMS
Category: Ulcer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Axid Overview

Nizatidine is a histamine H2 receptor antagonist that inhibits stomach acid production, and is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. It was developed by Eli Lilly and is marketed under the brand names Tazac and Axid. Contents 1 Clinical use 2 Adverse effects 3 History and development 4 See also 5 References 6 External links Clinical use Main article: H2 antagonist Nizatidine is used to treat duodenal ulcers, gastric ulcers, and ga...

Read more Axid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nizatidine

Recent Axid Forums:

Possible Dosages for this and Related Drugs:

NDC Database Records for Axid: (1 result)

Sorted by National Drug Code

• 52268-147 Axid 15 mg/ml Oral Solution by Braintree Laboratories, Inc.

Other drugs which contain Nizatidine or a similar ingredient: (1 result)

• NIZATIDINE 3 discussions

Related Axid Topics: